Treatment Strategies In Patients With Uterine Myomas | OMICS International| Journal Of Community Medicine And Health Education

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Treatment Strategies In Patients With Uterine Myomas

Uterine myomas are benign, hormone-sensitive, fibromuscular tumors that diagnosed in about 25%-40% of women during their reproductive age. Uterine myomas may be asymptomatic or they can cause abnormal uterine bleeding, pelvic pain, pressure complaints, pregnancy-related complications and infertility. The management of women with uterine myomas remains controversial. Various treatment protocols use medical treatment (GnRH analogues), radiological intervention (uterine artery embolization, focused ultrasound surgery) or surgical intervention (myomectomy, hysterectomy). Recent advances in the nonsurgical management of uterine myomas have shown promising results simplifying or eliminating the need for surgical intervention
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on March, 2023